People: Navidea Biopharmaceuticals Inc (NAVB.K)

NAVB.K on American Stock Exchange

1.26USD
21 Aug 2014
Price Change (% chg)

$0.01 (+0.80%)
Prev Close
$1.25
Open
$1.25
Day's High
$1.26
Day's Low
$1.24
Volume
195,986
Avg. Vol
870,534
52-wk High
$3.15
52-wk Low
$1.11

Search Stocks

Drake, Peter 

Brief Biography

Dr. Peter F. Drake is an Independent Director of Navidea Biopharmaceuticals, Inc. Dr. Drake began his career as a biotechnology analyst at Kidder, Peabody and Co. where he was a partner and head of the Healthcare Research Group. In 1988, Dr. Drake co-founded Vector Securities International, an investment banking firm specializing in the life sciences industry, where he was Executive Vice President and Director of Research. In 1993, Dr. Drake co-founded Vector Fund Management, a life sciences venture fund, and Deerfield Management, a healthcare hedge fund. In 1999, Vector Securities International was purchased by Prudential Securities, where he was a Managing Director and Head of Healthcare Research. Dr. Drake has served on the board of directors of Penwest Pharmaceuticals, a publicly traded specialty pharmaceutical company, which was purchased in 2010. He currently is a board member of Trustmark Insurance, a mutual insurance company; Rodman and Renshaw, a publicly traded investment banking firm; and Cortex Pharmaceuticals, a public neuroscience company. Dr. Drake received his undergraduate degree from Bowdoin College, and his Ph.D. in neurobiology and biochemistry from Bryn Mawr College.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gordon Troup

--

Thomas Tulip

731,010

Michael Goldberg

--

Brent Larson

593,064

Frederick Cope

599,400

William Regan

--
As Of 30 Dec 2013
Search Stocks